Nasal Polyposis: A Model of Chronic Airways Inflammation

  • César Picado
Part of the Allergy Frontiers book series (ALLERGY, volume 3)


Nasal polyps are benign tumours that usually occur in association with chronic rhinosinusitis. A variety of inflammatory mediators including cytokines, chemokines, mucines, prostaglandins, leukotrienes and matrix metalloproteinases, contribute to the inflammatory and remodelling process that takes place in the nasal mucosa. The pathogenesis of nasal polyposis is still an enigma; however, the molecular biology of the disease is beginning to unravel.


Nasal Mucosa Allergy Clin Immunol Nasal Polyposis Chronic Rhinosinusitis Nasal Polyposis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005;60:583–601.PubMedCrossRefGoogle Scholar
  2. 2.
    Pawankar R, Novaka M. Inflammatory mechanisms and remodelling in chronic rhinosinusitis and nasal polyps. Cur Allergy Asthma Rep 2007;7:202–208.CrossRefGoogle Scholar
  3. 3.
    Maldonado M, Martinez A, Alobid I, Mullol J. The antrochoanal polyp. Rhinology 2004;43:178–182.Google Scholar
  4. 4.
    Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231–236.PubMedCrossRefGoogle Scholar
  5. 5.
    Kowalski M. Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different? Thorax 2000;55(Suppl 2):s84–s86.PubMedCrossRefGoogle Scholar
  6. 6.
    Hellquist HB. Histopathology. In: Settipane GA Ed. Nasal polyps: epidemiology, pathogenesis and treatment. Oceanside, Providence, RI, pp. 31–39.Google Scholar
  7. 7.
    Stoop AE, Hameleers DM, van Run PE, et al. Lymphocytes and non-lymphoid cells in the nasal mucosa of patients with nasal polyps and healthy subjects. J Allergy Clin Immunol 1989;84:734–741.PubMedCrossRefGoogle Scholar
  8. 8.
    Fokkens WJ, Holm AF, Rijntjes E, et al. Characterization and quantification of cellular infiltrates in nasal mucosa of patients with grass pollen allergy, non-allergic patients with nasal polyps and controls. Int Arch Allergy Appl Immunol 1990;93:66–72.PubMedGoogle Scholar
  9. 9.
    Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1998;158:3902–3908.Google Scholar
  10. 10.
    Bachert C, Wagenmann M, Huaser U, et al. IL-5 synthesis is upregulated in human nasal polyps. J Allergy Clin Immunol 1997;99:837–842.PubMedCrossRefGoogle Scholar
  11. 11.
    Bachert C, Wagenmann M, Rudack C, Hopken K, Hillebrandt M, Wang D, van Cauwenberge P. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998;53:2–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Lee CH, Rhee CS, Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol 1998;107:665–670.PubMedGoogle Scholar
  13. 13.
    Lee CH, Le KS, Rhee CS, Lee SO, Min YG. Distribution of RANTES and interleukin-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1999;108:594–598.PubMedGoogle Scholar
  14. 14.
    Mullol J, Xaubet A, Gaya A, et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995;25:607–615.PubMedCrossRefGoogle Scholar
  15. 15.
    Xaubet A, Mullol J, Loez E, et al. Comparison of the role of nasal polyps and normal nasal mucosa epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy 1994;24:307–317.PubMedCrossRefGoogle Scholar
  16. 16.
    Im GJ, Hwang CS, Jung HH. Quantitative expression levels of regulated on activation Tcell expressed and secreted and eotaxin transcripts in toluene diisozyanate-induced allergic rats. Acta Otolaryngol 2005;125:370–377.PubMedGoogle Scholar
  17. 17.
    Min YG, Kim YJ, Yun YS. Distribution of eosinophilic granule proteins in nasal mucosa of atopic patients with nasal polyposis. ORL 1996;58:82–86.PubMedCrossRefGoogle Scholar
  18. 18.
    Bernstein JM, Ballow M, Rich G, Allen C, Swanson M, Dmochowski J. Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp ? Otolaryngol Head Neck Surg 2004;130:526–535.PubMedCrossRefGoogle Scholar
  19. 19.
    Morinaka S, Nakamura H. Inflammatory cells in nasal mucosa and nasal polyps. Auris Nasus Larynx 2000;27:59–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Sanchez Segura A, Brieva JA, Rodriguez C. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 1998;102:953–960.PubMedCrossRefGoogle Scholar
  21. 21.
    Hoffman HA, Wasserman SI. Chemical mediators in polyps. In: Settipane GA Ed. Nasal polyps: epidemiology, pathogenesis and treatment. Oceanside. Providence, RI, pp. 41–47.Google Scholar
  22. 22.
    Di Lorenzo G, Drago A, Esposito Pelliteri M, et al. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol 2001;125:164–175.PubMedCrossRefGoogle Scholar
  23. 23.
    Furukawa M, Ogura M, Tsutsumi T, Ssuji H, Yamashita T. Presence of platelet-activating factor in nasal polyps and eosinophils. Acta Otolaryngol 2002;122:872–876.PubMedCrossRefGoogle Scholar
  24. 24.
    Picado C. Mechanisms of aspirin sensitivity. Curr Allergy Asthma Rep 2006;6:198–202.PubMedCrossRefGoogle Scholar
  25. 25.
    Perez Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyps. J Allergy Clin Immunol 2006;115:1189–1196.CrossRefGoogle Scholar
  26. 26.
    Sousa AR, Perikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493–1499.PubMedCrossRefGoogle Scholar
  27. 27.
    Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004;113:277–283.PubMedCrossRefGoogle Scholar
  28. 28.
    Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999;160:291–296.PubMedGoogle Scholar
  29. 29.
    Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of Cox-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol 2004;114:814–819.PubMedCrossRefGoogle Scholar
  30. 30.
    Roca-Ferrer J, Pujols L, Gartner S, et al. Up-regulation of Cox-1 and Cox-2 in nasal polyps in cystic fibrosis. Thorax 2006;61:592–596.PubMedCrossRefGoogle Scholar
  31. 31.
    Martinez-Anton A, Roca-Ferrer J, Mullol J, et al. Mucin gene expresión in rhinitis sindromes. Curr Allergy Asthma Rep 2006;6:189–197.PubMedCrossRefGoogle Scholar
  32. 32.
    Martinez-Anton A, de Bolos C, Garrido M, et al. Mucin genes have different expresión patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy 2006;36:448–457.PubMedCrossRefGoogle Scholar
  33. 33.
    Shin SH, Park JY, Jeon CH, Choi JK, Lee SH. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope 2000;110:1353–1357.PubMedCrossRefGoogle Scholar
  34. 34.
    Hirschberg A, Jokuti A, Darvas Z, Almay K, Repassy G, Falus A. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-β1. Laryncoscope 2003;113:120–124.CrossRefGoogle Scholar
  35. 35.
    Wang QP, Escudier E, Roudot-Thoraval F, et al. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 1997;107:926–931.PubMedCrossRefGoogle Scholar
  36. 36.
    Lechapt-Zalcman E, Coste A, d'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001;193:223–241.CrossRefGoogle Scholar
  37. 37.
    Watelet JB, Bachert C, Claeys C, van Cauwenberge P. Matrix metalloproteinases MMP7,MMP-9 and their tissue inhibitor TIMP-1 expression in chronic sinusitis vs nasal polyps. Allergy 2004;59:54–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Kostomo K, Tervahartrada T, Sorsa T, Richardson M, Toskale E. Metalloproteinase function in chronic rhinosinustis with nasal polyposis. Laryngoscope 2007;117:638–643.CrossRefGoogle Scholar
  39. 39.
    Bernstein JM, Gorfien J, Noble B, Yankaskas JR. Nasal polypsosis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps). J Allergy Clin Immunol 1997;99:165–175.PubMedCrossRefGoogle Scholar
  40. 40.
    Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002;110:862–866.PubMedCrossRefGoogle Scholar
  41. 41.
    Ponikau JU, Sherris DA, Kephart GM, Adolphson C, Kita H. The role of ubiquitous airbone fungi in chronic rhinosinusitis. Clin Rev Allergy Immunol 2006;30:187–194.PubMedCrossRefGoogle Scholar
  42. 42.
    Ebbens FA, Scadding GG, Badia L, et al. Amphotericin B nasal lavages: not as solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006;118:1149–1156.PubMedCrossRefGoogle Scholar
  43. 43.
    Bachert C, van Zele T, Gevaert P, De Schrijver L, Van Cauwenberge P. Superantigens and nasal polyps. Curr Allergy Asthma Rep 2003;3:523–531.PubMedCrossRefGoogle Scholar
  44. 44.
    Bernstein JM, Kansal R. Superantigen hypothesis for the early development of chronic hyperplastic sinusitis with massive nasal polyposis. Cur Opin Otolaryngol Head Neck Surg 2005;13:39–44.CrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • César Picado
    • 1
  1. 1.Department of Pneumology and Respiratory Allergy Hospital ClinicUniversity of BarcelonaBarcelonaSpaine

Personalised recommendations